P2Yreceptor on the verge of a neuroinflammatory breakdown

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Amadio, Susanna ^a   Parisi, Chiara ^b   Montilli, Cinzia ^a   Carrubba, Alberto Savio ^a   Apolloni, Savina ^a   Volonté, Cinzia ^a,b  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTEGRIN; BETA3 INTEGRIN; CHLORDANE; GLIAL FIBRILLARY ACIDIC PROTEIN; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; MYELIN BASIC PROTEIN; PURINERGIC P2X RECEPTOR; PURINERGIC P2Y12 RECEPTOR; PURINERGIC P2 RECEPTOR;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY LABELING; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL COMMUNICATION; CELL SPECIFICITY; CEREBELLAR SLICE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CORPUS STRIATUM; HUMAN; MICROGLIA; MOUSE; MULTIPLE SCLEROSIS; MYELINATED NERVE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OLIGODENDROGLIA; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD TRANSSECTION; ANIMAL; CELL CULTURE; IMMUNOLOGY; METABOLISM; WISTAR RAT;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CELLS, CULTURED; HUMANS; MICE; MICROGLIA; OLIGODENDROGLIA; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P2;

EID: 84919812001     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/975849     Document Type: Article

References (60)

1. N. Guerout, X. Li, and F. Barnabe-Heider, "Cell fate control in the developing central nervous system, " Experimental Cell Research, vol. 321, no. 1, pp. 77-83, 2014.
2. T. Philips and W. Robberecht, "Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation inmotor neuron disease, " The Lancet Neurology, vol. 10, no. 3, pp. 253-263, 2011.
3. E. Ellwardt and F. Zipp, "Molecular mechanisms linking neuroinflammation and neurodegeneration in MS, " Experimental Neurology, 2014.
4. J. G. Walsh, D. A. Muruve, and C. Power, "Inflammasomes in the CNS, " Nature Reviews Neuroscience, vol. 15, no. 2, pp. 84-97, 2014.
5. F. di Virgilio, S. Ceruti, P. Bramanti, and M. P. Abbracchio, "Purinergic signalling in inflammation of the central nervous system, " Trends in Neurosciences, vol. 32, no. 2, pp. 79-87, 2009.
6. C. Volonte, S. Apolloni, S. D. Skaper, and G. Burnstock, "P2X7 Receptors: channels, pores and more, " CNS and Neurological Disorders-Drug Targets, vol. 11, no. 6, pp. 705-721, 2012.
7. G. A. Weisman, J. M. Camden, T. S. Peterson, D. Ajit, L. T. Woods, and L. Erb, "P2 receptors for extracellular nucleotides in the central nervous system: role of P2X7 and P2Y2 receptor interactions in neuroinflammation, " Molecular Neurobiology, vol. 46, no. 1, pp. 96-113, 2012.
8. G. Hollopeter, H. Jantzen, D. Vincent et al. , "Identification of the platelet ADP receptor targeted by antithrombotic drugs, " Nature, vol. 409, no. 6817, pp. 202-207, 2001.
9. C. Gachet, "The platelet P2 receptors as molecular targets for old and newantiplatelet drugs, " Pharmacology andTherapeutics, vol. 108, no. 2, pp. 180-192, 2005.
10. C. Gachet, "P2Y12 receptors in platelets and other hematopoietic and non-hematopoietic cells, " Purinergic Signalling, vol. 8, no. 3, pp. 609-619, 2012.
11. H. Franke, U. Krugel, J. Grosche et al. , "P2Y receptor expression on astrocytes in the nucleus accumbens of rats, " Neuroscience, vol. 127, no. 2, pp. 431-441, 2004.
12. S. Amadio, G. Tramini, A. Martorana et al. , "Oligodendrocytes express P2Y12 metabotropic receptor in adult rat brain, " Neuroscience, vol. 141, no. 3, pp. 1171-1180, 2006.
13. S. Amadio, C. Montilli, R. Magliozzi, G. Bernardi, R. Reynolds, and C. Volonte, "P2Y12 receptor protein in cortical gray matter lesions in multiple sclerosis, " Cerebral Cortex, vol. 20, no. 6, pp. 1263-1273, 2010.
14. S. Amadio, S. Apolloni, N. DAmbrosi, and C. Volonte, "Purinergic signalling at the plasma membrane: a multipurpose and multidirectionalmode to deal with amyotrophic lateral sclerosis and multiple sclerosis, " Journal of Neurochemistry, vol. 116, no. 5, pp. 796-805, 2011.
15. J. Dennis, M. K. Morgan, M. R. Graf, and B. Fuss, "P2Y 12 receptor expression is a critical determinant of functional responsiveness to ATXs MORFO domain, " Purinergic Signalling, vol. 8, no. 2, pp. 181-190, 2012.
16. Y. Sasaki, M. Hoshi, C. Akazawa et al. , "Selective Expression of Gi/o-Coupled ATP Receptor P2Y12 in Microglia in Rat Brain, " Glia, vol. 44, no. 3, pp. 242-250, 2003.
17. K. Nasu-Tada, S. Koizumi, and K. Inoue, "Involvement of β1 integrin in microglial chemotaxis and proliferation on fibronectin: different regulations by ADP through PKA, " GLIA, vol. 52, no. 2, pp. 98-107, 2005.
18. S. E. Haynes, G. Hollopeter, G. Yang et al. , "The P2Y12 receptor regulates microglial activation by extracellular nucleotides, " Nature Neuroscience, vol. 9, no. 12, pp. 1512-1519, 2006.
19. H. Kettenmann, U. K. Hanisch, M. Noda, and A. Verkhratsky, "Physiology of microglia, " Physiological Reviews, vol. 91, no. 2, pp. 461-553, 2011.
20. K. Kobayashi, H. Yamanaka, T. Fukuoka, Y. Dai, K. Obata, and K. Noguchi, "P2Y12 receptor upregulation in activated microglia is a gateway of p38 signaling and neuropathic pain, " Journal of Neuroscience, vol. 28, no. 11, pp. 2892-2902, 2008.
21. J. M. Crain, M. Nikodemova, and J. J. Watters, "Expression of P2 nucleotide receptors varies with age and sex in murine brain microglia, " Journal of Neuroinflammation, vol. 6, article 24, 2009.
22. S. Apolloni, S. Amadio, C. Montilli, C. Volonte, and N. D'Ambrosi, "Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis, " Human Molecular Genetics, vol. 22, no. 20, pp. 4102-4116, 2013.
23. A. C. Ludolph, C. Bendotti, E. Blaugrund et al. , "Guidelines for preclinical animal research in ALS/MND: a consensus meeting, " Amyotrophic Lateral Sclerosis, vol. 11, no. 1-2, pp. 38-45, 2010.
24. S. Apolloni, C. Parisi, M. G. Pesaresi et al. , "TheNADPHoxidase pathway is dysregulated by the P2X7 receptor in the sod1-g93a microglia model of amyotrophic lateral sclerosis, " Journal of Immunology, vol. 190, no. 10, pp. 5187-5195, 2013.
25. Y. Chen, V. Balasubramaniyan, J. Peng et al. , "Isolation and culture of rat and mouse oligodendrocyte precursor cells, " Nature Protocols, vol. 2, no. 5, pp. 1044-1051, 2007.
26. L. Stoppini, P.-A. Buchs, and D. Muller, "A simple method for organotypic cultures of nervous tissue, " Journal of Neuroscience Methods, vol. 37, no. 2, pp. 173-182, 1991.
27. I. Dusart, M. S. Airaksinen, and C. Sotelo, "Purkinje cell survival and axonal regeneration are age dependent: an in vitro study, " Journal of Neuroscience, vol. 17, no. 10, pp. 3710-3726, 1997.
28. I. von Kugelgen, "Pharmacological profiles of cloned mammalian P2Y-receptor subtypes, " Pharmacology and Therapeutics, vol. 110, no. 3, pp. 415-432, 2006.
29. P. J. Kersey, D. M. Staines, D. Lawson et al. , "Ensembl Genomes: an integrative resource for genome-scale data from nonvertebrate species, " Nucleic Acids Research, vol. 40, no. 1, pp. D91-D97, 2012.
30. K. D. Pruitt, G. R. Brown, S. M. Hiatt et al. , "RefSeq: an update on mammalian reference sequences, " Nucleic Acids Research, vol. 42, pp. D756-D763, 2014.
31. W. J. Kent, "BLAT-the BLAST-like alignment tool, " Genome Research, vol. 12, no. 4, pp. 656-664, 2002.
32. D. Ito, Y. Imai, K. Ohsawa, K. Nakajima, Y. Fukuuchi, and S. Kohsaka, "Microglia-specific localisation of a novel calcium binding protein, Iba1, " Molecular Brain Research, vol. 57, no. 1, pp. 1-9, 1998.
33. G. M. Hayes, M. N. Woodroofe, and M. L. Cuzner, "Microglia express MHC class II in normal and demyelinating human white matter, " Annals of the New York Academy of Sciences, vol. 540, pp. 501-503, 1988.
34. L. Bo, S. Mork, P. A. Kong, H. Nyland, C. A. Pardo, and B. D. Trapp, "Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions, " Journal of Neuroimmunology, vol. 51, no. 2, pp. 135-146, 1994.
35. B. D. Trapp, J. Peterson, R. M. Ransohoff, R. Rudick, S. Mork, and L. Bo, "Axonal transection in the lesions of multiple sclerosis, " TheNew England Journal of Medicine, vol. 338, no. 5, pp. 278-285, 1998.
36. M. Olah, K. Biber, J. Vinet, and H. W. G. M. Boddeke, "Microglia phenotype diversity, " CNS and Neurological Disorders-Drug Targets, vol. 10, no. 1, pp. 108-118, 2011.
37. L. Pont-Lezica, C. Bechade, Y. Belarif-Cantaut, O. Pascual, and A. Bessis, "Physiological roles of microglia during development, " Journal of Neurochemistry, vol. 119, no. 5, pp. 901-908, 2011.
38. G. J. Harry, "Microglia during development and aging, " Pharmacology & Therapeutics, vol. 139, no. 3, pp. 313-326, 2013.
39. J. S. Henkel, D. R. Beers, W. Zhao, and S. H. Appel, "Microglia in ALS: the good, the bad, and the resting, " Journal of Neuroimmune Pharmacology, vol. 4, no. 4, pp. 389-398, 2009.
40. M. C. Evans, Y. Couch, N. Sibson, and M. R. Turner, "Inflammation and neurovascular changes in amyotrophic lateral sclerosis, " Molecular and Cellular Neuroscience, vol. 53, pp. 34-41, 2013.
41. D. Y. Vogel, E. J. Vereyken, J. E. Glim et al. , "Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status, " Journal of Neuroinflammation, vol. 10, article 35, 2013.
42. V. E. Miron, A. Boyd, J. W. Zhao et al. , "M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination, " Nature Neuroscience, vol. 16, no. 9, pp. 1211-1218, 2013.
43. C. Volonte, S. Apolloni, M. T. Carri, and N. DAmbrosi, "ALS: focus on purinergic signalling, " Pharmacology and Therapeutics, vol. 132, no. 1, pp. 111-122, 2011.
44. S. Amadio, A. de Ninno, C. Montilli, L. Businaro, A. Gerardino, and C. Volonte, "Plasticity of primary microglia on micropatterned geometries and spontaneous long-distance migration in microfluidic channels, " BMC Neuroscience, vol. 14, article 121, 2013.
45. S. L. Sandowand T. H. Grayson, "Limits of isolation and culture: Intact vascular endothelium and BK Ca, " The American Journal of Physiology: Heart and Circulatory Physiology, vol. 297, no. 1, pp. H1-H7, 2009.
46. S. M. O. Hourani and D. A. Hall, "P2T purinoceptors: ADP receptors on platelets, " CIBA Foundation Symposia, vol. 198, pp. 53-70, 1996.
47. J. L. Daniel, C. Dangelmaier, J. Jin, B. Ashby, J. B. Smith, and S. P. Kunapuli, "Molecular basis for ADP-induced platelet activation I. Evidence for three distinct ADP receptors on human platelets, "The Journal of Biological Chemistry, vol. 273, no. 4, pp. 2024-2029, 1998.
48. G. E. Jarvis, R. G. Humphries, M. J. Robertson, and P. Leff, "ADP can induce aggregation of human platelets via both P2Y1 and P2T receptors, " British Journal of Pharmacology, vol. 129, no. 2, pp. 275-282, 2000.
49. P. Andre, S. M. Delaney, T. La Rocca et al. , "P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries, " Journal of Clinical Investigation, vol. 112, no. 3, pp. 398-406, 2003.
50. D. C. B. Mills, R. Puri, C.-J. Hu et al. , "Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 12, no. 4, pp. 430-436, 1992.
51. C. Gachet, P. Savi, P. Ohlmann, J.-P. Maffrand, K. H. Jakobs, and J.-P. Cazenave, "ADP receptor induced activation of guanine nucleotide binding proteins in rat platelet membranes: an effect selectively blocked by the thienopyridine clopidogrel, " Journal ofThrombosis and Haemostasis, vol. 68, no. 1, pp. 79-83, 1992.
52. K. Schror, "The basic pharmacology of ticlopidine and clopidogrel, " Platelets, vol. 4, no. 5, pp. 252-261, 1993.
53. P. Savi, J. Combalbert, C. Gaich et al. , "The antiaggregating activity of clopidogrel is due to a metabolic activation by the hepatic cytochrome P450-1A, " Thrombosis and Haemostasis, vol. 72, no. 2, pp. 313-317, 1994.
54. I. Shalito, O. Kopyleva, and V. Serebruany, "Novel antiplatelet agents in development: prasugrel, ticagrelor, and cangrelor and beyond, " American Journal of Therapeutics, vol. 16, no. 5, pp. 451-458, 2009.
55. M. Cattaneo, "New P2Y12 blockers, " Journal ofThrombosis and Haemostasis, vol. 7, supplement 1, pp. 262-265, 2009.
56. T. M. Quinton, S. Kim, J. Jin, and S. P. Kunapuli, "Lipid rafts are required in Gαi signaling downstream of the P2Y12 receptor during ADP-mediated platelet activation, " Journal of Thrombosis and Haemostasis, vol. 3, no. 5, pp. 1036-1041, 2005.
57. F. Vacca, S. Amadio, G. Sancesario, G. Bernardi, and C. Volonte, "P2X3 receptor localizes into lipid rafts in neuronal cells, " Journal of Neuroscience Research, vol. 76, no. 5, pp. 653-661, 2004.
58. P. Savi, J. Zachayus, N. Delesque-Touchard et al. , "The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts, " Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 29, pp. 11069-11074, 2006.
59. K. Schicker, S. Hussl, G. K. Chandaka et al. , "A membrane network of receptors and enzymes for adenine nucleotides and nucleosides, " Biochimica et Biophysica Acta, vol. 1793, no. 2, pp. 325-334, 2009.
60. S. Honda, Y. Sasaki, K. Ohsawa et al. , "ExtracellularATP orADP induce chemotaxis of cultured microglia through Gi/o-coupled P2Y receptors, " Journal of Neuroscience, vol. 21, no. 6, pp. 1975-1982, 2001.